China’s Role as Global Drug Hub Raises Alarms in Washington

Sept. 27, 2019, 2:04 PM

A California congresswoman plans to hold a hearing in about a month to explore the national-security risks posed by China’s dominance of the U.S. pharmaceutical supply chain, escalating concerns raised by the Pentagon.

Rep. Anna Eshoo (D-Calif.) is warning fellow lawmakers that if the trade war between Washington and Beijing were to intensify, China could throw the U.S. into chaos by cutting off the vast supply of important drug components made in the Asian nation.

“This would be one hell of a card for them to play,” Eshoo said in an interview in her office in Washington. “It would bring America to ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.